SCHEMBL16612958

SCHEMBL16612958

O=C(O)Oc1ncoc1-c1cccc(OC(F)(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STK17B O94768 1/20 0.43
CTSA P10619 2/20 0.42
FFAR1 O14842 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
DYRK1A Q13627 1/20 0.41
DHODH Q02127 6/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SLC6A7 Q99884 1/20 0.40
DHFR P00374 1/20 0.39
SLC13A5 Q86YT5 1/20 0.39
GSK3B P49841 1/20 0.39
PDE10A Q9Y233 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15189706 0.84 GSK3B (0.51) DYRK1AKDM4EMEN1ALDH1A1CYP1A2
SCHEMBL1167452 0.82 GSK3B (0.47) STK17BCTSAFFAR1FFAR4DYRK1A
SCHEMBL16612941 0.82 IP6K1 (0.46) KDM4EALDH1A1CYP1A2XDH
SCHEMBL16612795 0.81 KDM4E (0.43) FFAR1KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL16612946 0.80 ADORA2A (0.44) FFAR4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL9899922 0.79 ADORA2A (0.58) CTSADYRK1AKDM4EMEN1KMT2A
SCHEMBL17746038 0.79 FFAR1 (0.44) CTSAFFAR1FFAR4DHODHDHFR
SCHEMBL5546097 0.78 ADORA2A (0.54) KDM4EMEN1ALDH1A1CYP1A2CYP3A4
SCHEMBL15189624 0.78 MEN1 (0.46) KDM4EMEN1ALDH1A1KMT2A
SCHEMBL16613030 0.78 KMO (0.42) FFAR1KDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2675801-B1 NOVEL PYRAZOLE AND IMIDAZOLE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2015-04-08 EP claimed